FDA Adds Warning to Osteoporosis Drug for Hypocalcemia Risk ...Middle East

Medscape - News
Based on a completed data review, the agency concluded that denosumab increases the risk for severe hypocalcemia in patients with chronic kidney disease. Medscape Medical News

Hence then, the article about fda adds warning to osteoporosis drug for hypocalcemia risk was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Adds Warning to Osteoporosis Drug for Hypocalcemia Risk )

Apple Storegoogle play

Last updated :

Also on site :